Actinium Pharmaceuticals, Inc. To Present At The 2014 Biotechnology Industry Organization (BIO) International Convention In San Diego On June 26th

Published: Jun 23, 2014

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Actinium Pharmaceuticals, Inc. (NYSE MKT:ATNM) (“Actinium” or “the Company”), a biopharmaceutical company developing innovative targeted payload immunotherapeutics for the treatment of advanced cancers, today announced that Dr. Kaushik J. Dave, President and CEO of Actinium, will present a corporate update at the 2014 BIO International Convention in San Diego, CA on June 26th, 2014.

Help employers find you! Check out all the jobs and post your resume.

Back to news